688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 27.59
- +1.24+4.71%
Brightgene Bio-Medical Technology Co.,Ltd. News
Investor Research Report September 18, 2024 to September 20, 2024
Minsheng Securities Co., Ltd.\'s inspection opinion on Borui Biopharmaceuticals (Suzhou) Co., Ltd. providing guarantees for wholly-owned subsidiaries to carry out financial leasing business
Verification opinions of Minsheng Securities Co., Ltd. on capital increase and stock expansion of the holding subsidiary of Borui Biopharmaceuticals (Suzhou) Co., Ltd. and related transactions
Resolutions of the Second Special Meeting of Independent Directors of the Third Board of Directors
Announcement of Resolutions of the 27th Meeting of the Third Board of Supervisors
Inspection opinions of Minsheng Securities Co., Ltd. on the change of implementing entities for some fund-raising projects of Borui Biopharmaceuticals (Suzhou) Co., Ltd.
Investor Research Report September 3, 2024 to September 13, 2024
Investor Research Report August 27, 2024
Investor Research Report August 23, 2024
Brightgene Bio-Medical Technology Co.,Ltd.: Minsheng Securities Co., Ltd. Continuous Supervision and Tracking Report on Borui Biomedical (Suzhou) Co., Ltd. in the first half of 2024.
Minsheng Securities Co., Ltd. Continuous Supervision and Tracking Report on Borui Biomedical (Suzhou) Co., Ltd. in the first half of 2024.
Half-year evaluation report of the "Quality Improvement and Efficiency Increase for Return" action plan for the year 2024.
Announcement of the Resolution of the 26th Meeting of the Third Board of Supervisors.
Company Bylaws (August 2024)
Statement and Commitment of Independent Director Candidate (Wu Yinghua)
Independent Director Candidate Statement and Commitment (Cheng Zengjiang)
Independent Director Candidate Statement and Commitment (Xu Dongdong)
Statement and commitment of the independent director nominee (Wu Yinghua)
Statement and Commitment of Independent Director Nominee (Xu Dongdong)
Statement and Commitment of Independent Director Nominee (Cheng Zengjiang)
Analysis
Price Target
No Data
No Data